This appeal was filed by the Suspended Directors of the Corporate Debtor challenging the order dated 17.04.2023 passed by the National Company Law Tribunal, Mumbai Bench-IV in MB-23/MB-IV/2019 approving the Resolution Plan submitted by the Successful Resolution Applicant. The Adjudicating Authority in its order dated 17.04.2023 also issued certain directions, leading the Appellant to feel aggrieved and file this appeal.
ICICI Bank filed an application under Section 7 of the Insolvency and Bankruptcy Code, 2016, initiating the Corporate Insolvency Resolution Process (CIRP) against Unimark Remedies Ltd., the Corporate Debtor. The CIRP commenced on 03.04.2018. A resolution plan submitted by a consortium including Asset Recovery Company (India) Ltd., Intas Pharmaceuticals Ltd., and Shamrock Pharmachemi P Ltd. was approved by the Committee of Creditors (CoC) with a 72.25% vote share. The Resolution Professional filed IA. No.23/MB-IV/2019 for approval of the Resolution Plan, which was allowed by the Adjudicating Authority. The suspended directors of the Corporate Debtor filed an appeal challenging the order approving the Resolution Plan. The appellants sought deletion of certain paragraphs
…Sign in to view the parties.
Corporate Insolvency…
E-voting held between 24th December, 2018 and…
This appeal was filed by the Suspended Directors of the Corporate Debtor challenging the order dated 17.04.2023 passed by the National Company Law Tribunal, Mumbai Bench-IV in MB-23/MB-IV/2019 approving the Resolution Plan submitted by the Successful Resolution Applicant. The Adjudicating Authority in its order dated 17.04.2023 also issued certain directions, leading the Appellant to feel aggrieved and file this appeal.
ICICI Bank filed an application under Section 7 of the Insolvency and Bankruptcy Code, 2016, initiating the Corporate Insolvency Resolution Process (CIRP) against Unimark Remedies Ltd., the Corporate Debtor. The CIRP commenced on 03.04.2018. A resolution plan submitted by a consortium including Asset Recovery Company (India) Ltd., Intas Pharmaceuticals Ltd., and Shamrock Pharmachemi P Ltd. was approved by the Committee of Creditors (CoC) with a 72.25% vote share. The Resolution Professional filed IA. No.23/MB-IV/2019 for approval of the Resolution Plan, which was allowed by the Adjudicating Authority. The suspended directors of the Corporate Debtor filed an appeal challenging the order approving the Resolution Plan. The appellants sought deletion of certain paragraphs
…Corporate Insolvency…
E-voting held between 24th December, 2018 and…